Bryce Point Capital, LLC Procept Bio Robotics Corp Transaction History
Bryce Point Capital, LLC
- $345 Billion
- Q4 2024
A detailed history of Bryce Point Capital, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bryce Point Capital, LLC holds 19,347 shares of PRCT stock, worth $1.28 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
19,347Holding current value
$1.28 Million% of portfolio
0.45%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
289Shares Held
40.8MCall Options Held
262KPut Options Held
232K-
Vanguard Group Inc Valley Forge, PA5.14MShares$340 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$231 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$116 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$98.7 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$79.9 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.95B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...